ERRATA

The November 20, 2012, article by Younes et al, entitled “Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes” (J Clin Oncol 30:4161–4167, 2012), contained an error.

The clinical trial information was given as NCT00481091, whereas it should have been NCT00741871.

The online version has been corrected in departure from the print. The authors apologize for the error.